Literature DB >> 3115209

Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.

C P Kales, J R Murren, R A Torres, J A Crocco.   

Abstract

One hundred forty-five patients were initially seen with Pneumocystis carinii pneumonia (PCP). Of the many features examined, several variables were identified early in the hospitalization for PCP that were associated with poor survival. These included multiple admissions, leukocytoses, elevated serum lactate dehydrogenase levels, decreased arterial oxygen pressure (tension), decreased arterial carbon dioxide pressure (tension), and decreased serum albumin levels. Variables that were associated with increased survival included normal respiratory rates and normal findings on lung examination. Patients with multiple pulmonary infections displayed higher mortality rates than patients who had only PCP. Finally, our data did not suggest that the degree of immunosuppression affected in-hospital mortality for PCP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115209

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  19 in total

Review 1.  AIDS and the lung. 7. Treatment of lung disease in patients with the acquired immune deficiency syndrome.

Authors:  D M Mitchell; M A Johnson
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

Review 2.  Aids and the lung. 6-- Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

3.  Case of undiagnosed pneumocystis pneumonia (PCP).

Authors:  Verda Arshad; Nousheen Iqbal; Haider Ali Saleem; Muhammad Irfan
Journal:  BMJ Case Rep       Date:  2017-10-24

4.  Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy.

Authors:  R F Miller; E Allen; A Copas; M Singer; S G Edwards
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

5.  Focal lung uptake of gallium-67 in patients with acquired immunodeficiency syndrome secondary to pneumocystis carinii pneumonia.

Authors:  M Charron; E S Ackerman; G M Kolodny; L Rosenthall
Journal:  Eur J Nucl Med       Date:  1988

6.  Serum lactic dehydrogenase predicts mortality in patients with AIDS and Pneumocystis pneumonia.

Authors:  M L Lipman; E Goldstein
Journal:  West J Med       Date:  1988-10

7.  Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.

Authors:  A Antinori; G Maiuro; F Pallavicini; F Valente; G Ventura; G Marasca; R Murri; E Pizzigallo; G Camilli; E Tamburrini
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

Review 8.  Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis.

Authors:  K A Freedberg; A N Tosteson; D J Cotton; L Goldman
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

9.  Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study.

Authors:  M W Fei; E J Kim; C A Sant; L G Jarlsberg; J L Davis; A Swartzman; L Huang
Journal:  Thorax       Date:  2009-10-12       Impact factor: 9.139

10.  Predicting in-hospital outcome in HIV-associated Pneumocystis carinii pneumonia.

Authors:  T Bauer; S Ewig; E Hasper; J K Rockstroh; B Lüderitz
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.